CRH
218 hedge funds and large institutions have $1.41B invested in CRH in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 69 increasing their positions, 83 reducing their positions, and 48 closing their positions.
124,517% more call options, than puts
Call options by funds: $15M | Put options by funds: $12K
0.02% less ownership
Funds ownership: 4.6% → 4.58% (-0.02%)
12% less funds holding
Funds holding: 247 → 218 (-29)
17% less repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 83
25% less capital invested
Capital invested by funds: $1.87B → $1.41B (-$461M)
52% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 48
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$41.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$14.3M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
+$12.8M |
| 4 |
CI
Conning Inc
Hartford,
Connecticut
|
+$8.45M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$7.71M |
Top Sellers
CRH Hedge Fund Activity: Q1 2022 in Review
218 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in CRH (CRH) for Q1 2022, worth a combined $1.41B — down 25% from $1.87B a quarter earlier.
Sellers outnumbered buyers: 48 funds closed out of CRH and 23 opened new positions — a net loss of 25 holders — while 83 trimmed existing stakes and 69 added.
The largest buyer was Fidelity Investments, adding an estimated $41.5M. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $21.5M.
- 218 institutional investors held CRH (CRH) as of Q1 2022, down from 247 in Q4 2021.
- Funds reported $1.41B of CRH stock for Q1 2022, down 25% quarter-over-quarter.
- 23 funds opened new CRH positions in Q1 2022 and 48 closed out, a net change of -25 holders.
- The largest CRH buyer in Q1 2022 was Fidelity Investments, an estimated $41.5M added.
- The largest CRH seller in Q1 2022 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $21.5M sold.
Based on aggregated 13F filings for Q1 2022.